Fuat Demirkıran

Prof. Fuat Demirkıran is a gynecologic oncology surgeon with a strong clinical and academic background. He completed his specialty training in Gynecologic Oncology Surgery at Istanbul University Cerrahpaşa Faculty of Medicine in 2011. Since 2002 he has been affiliated with Acıbadem Health Group, where he has developed expertise in diagnosis, surgical management, and follow‑up care for patients with gynecologic cancers. He is an active member of national and international professional societies, including the Gynecologic Oncology Society, the Turkish Gynecological and Obstetric Society, the Obstetric and Gynecologic Ultrasonography Society, and the Minimally Invasive Surgery Association. He is also a member of ESGO (European Society of Gynecological Oncology) and IGCS (International Gynecologic Cancer Society), reflecting his commitment to evidence‑based care and collaboration in the global gynecologic oncology community. His practice emphasizes advanced surgical techniques, minimally invasive approaches when appropriate, and the integration of imaging and multidisciplinary care to achieve the best outcomes for patients.

Education

• 2011 Istanbul University Cerrahpasa Faculty of Medicine Gynecologic Oncology Surgery
• 1999 Istanbul University Cerrahpaşa Faculty of Medicine / Professor
• 1993 Istanbul University Cerrahpasa Faculty of Medicine / Associate Professor
• 1990 Istanbul University Cerrahpaşa Faculty of Medicine Gynecology and Obstetrics
• 1976 – 1982 Istanbul University Istanbul Faculty of Medicine

Experience

• 2002 Acibadem Health Group
• 1999 Istanbul University Cerrahpasa Faculty of Medicine
• 1995 University Of Los Angeles California Clinical Trials In Gynecologic Oncology
• 1995 University Of Los Angeles
• 1993 Istanbul University Cerrahpasa Faculty of Medicine
• 1992 – 1993 Istanbul University Cerrahpasa Faculty of Medicine
• 1990 – 1991 Istanbul University Cerrahpasa Faculty of Medicine
• 1984 – 1985 Ilic Central Health Center
• 1982 Erzincan State Hospital Surgical Outpatient Clinic
• 1982 Erzincan State Hospital Surgery Clinic

Memberships

• Gynecologic Oncology Society
• Obstetric and Gynecologic Ultrasonography Society
• Minimally Invasive Surgery Association
• ESGO (European Society of Gynecological Oncology)
• IGCS (International Gynecologic Cancer Society)
• Turkish Gynecological and Obstetric Society

Publications

• COVIDSurg Collaborative; GlobalSurg Collaborative. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
  Anaesthesia. 2022 Jan;77(1):28-39. doi: 10.1111/anae.15563. Epub 2021 Aug 24. PMID: 34428858; PMCID: PMC8652887.
• Juvenile granulosa cell tumor: 20 years” experience of a Tertiary Center
  Ginekol Pol. 2022;93(10):787-792. doi: 10.5603/GP.a2022.0107. PMID: 36748172. Hamzaoğlu Canbolat K, Biçer E, İlvan Ş, Beşe T, Çepni İ, Demirkıran F.
• Diagnostic accuracy of sentinel node biopsy in non-endometrioid, high-grade and/or deep myoinvasive endometrial cancer: A Turkish gynecologic oncology group study (TRSGO-SLN-006).
  Gynecol Oncol. 2022 Mar;164(3):492-497. doi: 10.1016/j.ygyno.2022.01.009. Epub 2022 Jan 13. PMID: 35033380 Altin D, Taskin S, Ortac F, Tokgozoglu N, Vatansever D, Guler AH, Gungor M, Tasci T, Bese T, Turan H, Kahramanoglu I, Yalcin I, Celik C, Demirkiran F,
• SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer.
  Int J Gynecol Cancer. 2022 Oct 3;32(10):1236-1243. doi: 10.1136/ijgc-2022-003790. Erratum in: Int J Gynecol Cancer. 2023 Feb 6;33(2):316. PMID: 365837 Boria F, Chiva L, Chacon E, Zanagnolo V, Fagotti A, Kucukmetin A, Mom C, Chakalova G, Shamistan A, Malzoni M, Narducci F, Arencibia O, Raspagliesi F,
• The relationship between tumor mean standard uptake value (SUVmax) in preoperative PET/computed tomography and prognostic risk groups in endometrial cancer.
  Nucl Med Commun. 2023 Mar 1;44(3):204-211. doi: 10.1097/MNM.0000000000001654. Epub 2022 Dec 16. PMID: 36729416. Bese T, Bicer E, Tetikli Kosuk A, Akovali B, Turan H, Kabasakal L, Demirkiran F.
• A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/ /GOG-3020/ENGOT-ov45).
  J Clin Oncol.2022;40(34):3952-3964. doi:10.1200/JCO.22.01003 Monk BJ, Parkinson C, Lim MC, Demirkiran F. et all.
• Manzour N, Chiva L, Chacón E, Martin-Calvo N, Boria F, Minguez JA, Alcazar JL; SUCCOR Study Group.
  Ann Surg Oncol. 2022 Aug;29(8):4819-4829. doi: 10.1245/s10434-022-11671-5. Epub 2022 Apr 16. PMID: 35430668; PMCID: PMC9246807.
• Is the extent of lymphadenectomy a prognostic factor in International Federation of Gynecology and Obstetrics stage II endometrioid endometrial cancer
  J Obstet Gynaecol Res. 2021 Mar;47(3):1134-1144. doi: 10.1111/jog.14648. Epub 2021 Jan 10. PMID: 33426779. Cuylan ZF, Akilli H, Gungorduk K, Demirkiran F, Oz M, Salman MC, Sozen H, Celik H, Gokcu M, Bese T, Meydanli MM, Ozgul N, Topuz S, Kuscu E, Kuru O, Go
• A multicentric study of Turkish Society of Gynecologic Oncology (TRSGO-OvCa-001)
  J Surg Oncol. 2021 May;123(8):1801-1810. doi: 10.1002/jso.26450. Epub 2021 Mar 3. PMID: 33657253 Vatansever D, Taskiran C, Mutlu Meydanli M, Gungorduk K, Akbayir O, Yalcin I, Demirkiran F, Sozen H, Ozgul N, Celik H, Onan MA, Taskin S, Oge T, Simse
• Could the Long-Term Oncological Safety of Laparoscopic Surgery in Low-Risk Endometrial Cancer also Be Valid for the High-Intermediate- and High-Risk Patients?
  A Multi-Center Turkish Gynecologic Oncology Group Study Conducted with 2745 Endometrial Cancer Cases. (TRSGO-End-001). Curr Oncol. 2021 Oct 29;28(6):4 Vardar MA, Guzel AB, Taskin S, Gungor M, Ozgul N, Salman C, Kucukgoz-Gulec U, Khatib G, Taskiran C, Dünder I, Ortac F, Yuce K, Terek C, Simsek T,